BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Du L, Wu C, Yu B, Zhang H, An F. Peptide Sequence-Dominated Enzyme-Responsive Nanoplatform for Anticancer Drug Delivery. CTMC 2019;19:74-97. [DOI: 10.2174/1568026619666190125144621] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Cui J, Li C, Deng C, Deng G, Zhang H, An F. Biomaterial-assisted photoimmunotherapy for synergistic suppression of cancer progression. Chinese Chemical Letters 2023. [DOI: 10.1016/j.cclet.2023.108180] [Reference Citation Analysis]
2 Baker A, Khan MS, Iqbal MZ, Khan MS. Tumor-targeted Drug Delivery by Nanocomposites. Curr Drug Metab 2020;21:599-613. [PMID: 32433002 DOI: 10.2174/1389200221666200520092333] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Li Y, Zhang C, Li G, Deng G, Zhang H, Sun Y, An F. Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy. Acta Pharm Sin B 2021;11:2220-42. [PMID: 34522585 DOI: 10.1016/j.apsb.2021.01.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Irshad S, Siddiqui B, ur.Rehman A, Farooq RK, Ahmed N. Recent trends and development in targeted delivery of therapeutics through enzyme responsive intelligent nanoplatform. International Journal of Polymeric Materials and Polymeric Biomaterials 2022;71:403-13. [DOI: 10.1080/00914037.2020.1848829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li Y, Mei T, Han S, Han T, Sun Y, Zhang H, An F. Cathepsin B-responsive nanodrug delivery systems for precise diagnosis and targeted therapy of malignant tumors. Chinese Chemical Letters 2020;31:3027-40. [DOI: 10.1016/j.cclet.2020.05.027] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
6 Zhou M, Xie Y, Xu S, Xin J, Wang J, Han T, Ting R, Zhang J, An F. Hypoxia-activated nanomedicines for effective cancer therapy. Eur J Med Chem 2020;195:112274. [PMID: 32259703 DOI: 10.1016/j.ejmech.2020.112274] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
7 Qin X, Li Y. Strategies To Design and Synthesize Polymer‐Based Stimuli‐Responsive Drug‐Delivery Nanosystems. ChemBioChem 2020;21:1236-53. [DOI: 10.1002/cbic.201900550] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
8 Fujita H, Dou J, Matsumoto N, Wu Z, Lindsey JS. Enzymatically triggered chromogenic cross-linking agents under physiological conditions. New J Chem 2020;44:719-43. [DOI: 10.1039/c9nj04126e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Guo F, Fu Q, Jin C, Ji X, Yan Q, Yang Q, Wu D, Gao Y, Hong W, Li A, Yang G. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment. Drug Deliv 2019;26:1027-38. [PMID: 31691601 DOI: 10.1080/10717544.2019.1676843] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Shen G, Li Y, Zhao L, Wu H. Functional Peptides and Small Molecules in Medicinal Chemistry-Part I. Curr Top Med Chem 2019;19:2-3. [PMID: 30942146 DOI: 10.2174/156802661901190326145944] [Reference Citation Analysis]
11 Majumder J, Taratula O, Minko T. Nanocarrier-based systems for targeted and site specific therapeutic delivery. Adv Drug Deliv Rev 2019;144:57-77. [PMID: 31400350 DOI: 10.1016/j.addr.2019.07.010] [Cited by in Crossref: 99] [Cited by in F6Publishing: 107] [Article Influence: 24.8] [Reference Citation Analysis]